We are live on ! Find out more
BMRN icon

BioMarin Pharmaceuticals
BMRN

280 hedge funds and large institutions have $7.98B invested in BioMarin Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 280 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less call options, than puts

Call options by funds: $36.2M | Put options by funds: $43M

Holders
280
Holders Change
+280
Holders Change %
–
% of All Funds
9.14%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
280
Increased
–
Reduced
–
Closed
–
Calls
$36.2M
Puts
$43M
Net Calls
-$6.77M
Net Calls Change
-$6.77M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$947M +$1.06B +16,968,746 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$691M +$772M +12,386,926 New
Sands Capital Management
3
Sands Capital Management
Virginia
$632M +$707M +11,345,317 New
Primecap Management
4
Primecap Management
California
$429M +$479M +7,684,329 New
Jennison Associates
5
Jennison Associates
New York
$404M +$451M +7,233,923 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$395M +$441M +7,073,978 New
Capital World Investors
7
Capital World Investors
California
$205M +$229M +3,678,225 New
BIT
8
BlackRock Institutional Trust
California
$182M +$203M +3,256,727 New
State Street
9
State Street
Massachusetts
$174M +$194M +3,115,106 New
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$164M +$183M +2,941,290 New
CWAM
11
Columbia Wanger Asset Management
Illinois
$151M +$168M +2,700,000 New
Wells Fargo
12
Wells Fargo
California
$138M +$154M +2,473,890 New
AGA
13
Altrinsic Global Advisors
Connecticut
$138M +$154M +2,470,783 New
AC
14
Amici Capital
New York
$129M +$144M +2,306,354 New
TG
15
TCW Group
California
$128M +$143M +2,297,617 New
BFA
16
BlackRock Fund Advisors
California
$124M +$139M +2,224,275 New
Invesco
17
Invesco
Georgia
$119M +$133M +2,131,153 New
Deutsche Bank
18
Deutsche Bank
Germany
$116M +$129M +2,073,104 New
SAM
19
Sectoral Asset Management
Quebec, Canada
$110M +$123M +1,973,064 New
William Blair & Company
20
William Blair & Company
Illinois
$101M +$113M +1,810,834 New
BRC
21
Blue Ridge Capital
New York
$97.5M +$109M +1,750,000 New
JHIU
22
Janus Henderson Investors US
Colorado
$90.1M +$101M +1,614,189 New
MCM
23
Munder Capital Management
Michigan
$89.4M +$100M +1,604,529 New
Goldman Sachs
24
Goldman Sachs
New York
$78.6M +$87.9M +1,409,755 New
RIM
25
Rainier Investment Management
Washington
$77.8M +$86.9M +1,394,570 New
1
2 3 4 5

BMRN Hedge Fund Activity: Q2 2013 in Review

280 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in BioMarin Pharmaceuticals (BMRN) for Q2 2013, worth a combined $7.98B.

Buyers outnumbered sellers: 280 funds opened new BMRN positions and 0 closed out — a net gain of 280 holders — while 0 added to existing stakes and 0 trimmed.

  • 280 institutional investors held BioMarin Pharmaceuticals (BMRN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $7.98B of BioMarin Pharmaceuticals stock for Q2 2013.
  • 280 funds opened new BioMarin Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +280 holders.

Based on aggregated 13F filings for Q2 2013.